Transthyretin Val30Met familial amyloid polyneuropathy: A considerably different clinical picture and natural course in endemic and non-endemic areas

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 83, Issue 2, 2012, Pages 121-

  Ikeda, Shu Ichi ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; METHIONINE; PREALBUMIN; VALINE;

AMINO ACID SUBSTITUTION; DEATH; ECHOCARDIOGRAPHY; EDITORIAL; ENDEMIC DISEASE; FAMILIAL AMYLOID POLYNEUROPATHY; GENE; GENE MUTATION; HUMAN; MOTOR DYSFUNCTION; ONSET AGE; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; SENSORY NEUROPATHY; SYMPTOM; TRANSTHYRETIN GENE;

EID: 84855599279     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2011-301582     Document Type: Editorial

References (4)

1. Ikeda S, Nakazato M, Ando Y, et al. Familial transthyretin-type amyloid polyneuropathy in Japan: clinical and genetic heterogeneity. Neurology 2002;58:1001-7. (Pubitemid 34298536)
2. Misu K, Hattori N, Nagamatsu M, et al. Late-onset familial amyloid polyneuropathy type I (transthyretin Met30-associated familial amyloid polyneuropathy) unrelated to endemic focus in Japan. Clinicopathological and genetic features. Brain 1999;122:1951-62. (Pubitemid 29473866)
3. Plante-Bordeneuve V, Ferreira A, Lalu T, et al. Diagnostic pitfalls in sporadic transthyretin familial amyloid polyneuropathy (TTR-FAP). Neurology 2007;69:693-8. (Pubitemid 47256013)
4. Koike H, Tanaka F, Hashimoto R, et al. Natural history of transthyretin Val30Met familial amyloid polyneuropathy: analysis of late-onset cases from non-endemic areas. J Neurol Neurosurg Psychiatry 2012;83:152-8.